Skip to main content

Welltower Value Stock - Dividend - Research Selection

Welltower

ISIN: US95040Q1040 , WKN: A1409D

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Welltower Inc. (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people\'s wellness and overall health care experience. Welltower?, a real estate investment trust (\"REIT\"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. More information is available at www.welltower.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Wall Street Bullish on Welltower Inc. (WELL) Here’s Why

2026-02-25
Welltower Inc. (NYSE:WELL) is one of the Best Stocks to Buy and Hold For the Next 3 Years. Wall Street is bullish on Welltower Inc. (NYSE:WELL) after the company topped estimates during its fiscal Q4 2025 earnings, released on February 10. Recently, on February 24, Austin Wurschmidt from KeyBanc reiterated a Buy rating on the […]

RBC Capital Maintains Outperform on Welltower, Raises Price Target to $230

2026-02-24
RBC Capital analyst Michael Carroll maintains Welltower (NYSE:WELL) with a Outperform and raises the price target from $207 to $230.

Keybanc Maintains Overweight on Welltower, Raises Price Target to $240

2026-02-24
Keybanc analyst Austin Wurschmidt maintains Welltower (NYSE:WELL) with a Overweight and raises the price target from $210 to $240.

Real Estate Stocks Rise: Realty Income (O) & Simon Property (SPG) Lead Last Week’s Winners

2026-02-23
Markets have started the week on rocky footing. The Dow Jones is off 1.3% as of 1:45 p.m. ET in Monday trading, but real estate stocks are holding in relatively well. Looking at last week, real estate stocks had a quietly constructive week while the broader market barely moved. The S&P 500, as tracked by SPY, ... Real Estate Stocks Rise: Realty Income (O) & Simon Property (SPG) Lead Last Week’s Winners

Tariffs, Tensions, And Repriced Risk

2026-02-22

Morgan Stanley Raises Welltower (WELL) Price Target on Strong Growth Outlook

2026-02-21
Welltower Inc. (NYSE:WELL) is included among the 14 Best Real Estate Stocks to Buy According to Hedge Funds. On February 18, Morgan Stanley raised its price recommendation on Welltower Inc. (NYSE:WELL) to $215 from $200. The firm maintained an Overweight rating, signaling continued confidence in the company’s growth outlook. On the fourth-quarter earnings call, CEO […]

Medical Properties Q4 NFFO Beat Estimates, Revenues Rise Y/Y

2026-02-20
MPT tops Q4 NFFO and revenue estimates as rent billed jumps, while high interest expenses pressure results.

The State Of REITs: February 2026 Edition

2026-02-19

Harbor Dividend Growth Leaders ETF Q4 Contributors & Detractors

2026-02-18

What's going on in today's session: S&P500 movers

2026-02-18
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.